| Date Filed | Type | Description |
| 05/30/2023 |
4
| Duraibabu Prathyusha (SVP, CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,328 shares
@ $1.33, valued at
$1.8k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2023 |
4
| Duraibabu Prathyusha (SVP, CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 53,438 shares
@ $0
Paid exercise price by delivering 7,030 shares
@ $2.66, valued at
$18.7k
Granted 249,375 options to buy
@ $2.66, valued at
$663.3k
|
|
| 02/24/2023 |
4
| Duraibabu Prathyusha (Director) has filed a Form 4 on Organogenesis Holdings Inc.|
Txns:
| Granted 65,737 shares
@ $0 |
|
| 02/06/2023 |
4/A
| Duraibabu Prathyusha (SVP, CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 864 shares
@ $3.76, valued at
$3.2k
|
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2022 |
4
| Duraibabu Prathyusha (Vice President, Finance) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 662 shares
@ $4.83, valued at
$3.2k
|
|
| 03/29/2022 |
4
| Duraibabu Prathyusha (Vice President, Finance) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 345 shares
@ $5.75, valued at
$2k
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Duraibabu Prathyusha (Director) has filed a Form 4 on Organogenesis Holdings Inc.|
Txns:
| Granted 20,547 shares
@ $0 |
|
| 11/23/2021 |
4
| Duraibabu Prathyusha (Director) has filed a Form 4 on Organogenesis Holdings Inc.|
Txns:
| Granted 11,340 shares
@ $0 |
|
| 11/23/2021 |
3
| Duraibabu Prathyusha (Director) has filed a Form 3 on Organogenesis Holdings Inc. |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/27/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2020 |
4
| Duraibabu Prathyusha (VP Principal Acct. Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 647 shares
@ $8.32, valued at
$5.4k
|
|
| 03/26/2020 |
4
| Duraibabu Prathyusha (VP Principal Acct. Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 02/26/2020 |
4/A
| Duraibabu Prathyusha (VP Principal Acct. Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 16,500 shares
@ $0
Granted 33,000 options to buy
@ $6.8, valued at
$224.4k
|
|
| 02/26/2020 |
4
| Duraibabu Prathyusha (VP Principal Acct. Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 16,500 shares
@ $0
Granted 33,000 options to buy
@ $6.8, valued at
$224.4k
|
|
| 06/18/2019 |
3
| Duraibabu Prathyusha (VP, Principal Acct. Officer) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |